Open AccessOutcomes of Eyes Lost to Follow-Up in Patients with Central Retinal Vein Occlusion Who are Receiving Anti-Vascular Endothelial Growth Factor Treatment
Author(s) -
Kaibo Yang,
Lei Liu,
Hao Feng,
Jun Li,
Zheli Liu,
Henan Liu,
Han Zhang
Publication year - 2021
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s303248
Subject(s) - medicine , central retinal vein occlusion , ophthalmology , occlusion , vascular endothelial growth factor , retinal , retinal vein , central retinal vein , vegf receptors , macular edema
To evaluate the anatomic and functional outcomes in eyes of patients with macular edema (ME) caused by central retinal vein occlusion (CRVO) who were lost to follow-up (LTFU) for more than 6 months following treatment with anti-vascular endothelial growth factor (VEGF) therapy and to determine the predictive factors of visual prognosis in these patients.